In vivo purging and relapse prevention following ASCT

Agranulocytosis unresponsive to growth factors following rituximab in vivo purging.

the annexin V Kozak sequence (Ϫ1CϾT) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. Agranulocytosis unresponsive to growth factors following rituximab in vivo purging Rituximab, a chimeric monoclonal anti-CD20 antibody, has been successfully used to in vivo purge CD20 ϩ tumor cells during mobilization for high-...

Effectiveness of Psychodrama Therapy in Relapse Prevention and Rumination

Objective: The aim of this study was to investigate the effectiveness of psychodrama therapy in relapse prevention and rumination. Method: A semi-experimental research design along with pre-test/post-test and control group was employed for the conduct of this study. All the patients with drug abuse presenting to Tehran addiction treatment clinics constituted the statistical population of this s...

Relapse Prevention 1 RUNNING HEAD: Relapse Prevention

Relapse Prevention

Relapse prevention (RP) is an important component of alcoholism treatment. The RP model proposed by Marlatt and Gordon suggests that both immediate determinants (e.g., high-risk situations, coping skills, outcome expectancies, and the abstinence violation effect) and covert antecedents (e.g., lifestyle factors and urges and cravings) can contribute to relapse. The RP model also incorporates num...

Relapse Prevention

G. Alan Marlatt, Ph.D. is Professor of Psychology and director of the Addictive Behaviors Research Center where he conducts training and research on the prevention and treatment of alcohol and other addictive behavior problems in college students and Native American Youth as well as on the effects of Vipassana meditation on relapse and general well-being. He received his Ph.D. in psychology fro...